Список использованной литературы:

1. Клинические рекомендации Минздрава РФ по меланоме кожи и слизистых оболочек. https://cr.minzdrav.gov.ru/schema/546

2. Dunkin CSJ, Pleat JM, Gillespie PH, Tyler MPH, Roberts AHN, McGrouther DA. Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers. Plast Reconstr Surg. 2007 May;119(6):1722-1732.

3. Butzelaar L, Ulrich MM, Mink van der Molen AB, Niessen FB, Beelen RH. Currently known risk factors for hypertrophic skin scarring: A review. J Plast Reconstr Aesthet Surg. 2016 Feb;69(2):163-9.

4. Ogawa R, Dohi T, Tosa M, Aoki M, Akaishi S. The Latest Strategy for Keloid and Hypertrophic Scar Prevention and Treatment: The Nippon Medical School (NMS) Protocol. J Nippon Med Sch. 2021 Mar 11;88(1):2-9.

5. Rudolph R. Wide spread scars, hypertrophic scars and keloids. Clin Plast Surg 1987;14:253–60.

6. Akoh CC, Orlow SJ. A Review of Vitamin D and Scarring: The Potential for New Therapeutics. J Drugs Dermatol. 2020 Jul 1;19(7):742-745.

7. Никонорова В.Г., Криштоп В.В., Румянцева Т.А. Роль трансформирующего фактор роста бета-1 и фактора роста эндотелия сосудов в формировании кожных рубцов // Вестник Российского университета дружбы народов. Серия: Медицина. - 2021. - Т. 25. - №3. - C. 235-242.

8. Lees VC, Briggs JC. Effect of initial biopsy procedure on prognosis in Stage 1 invasive cutaneous malignant melanoma: review of 1086 patients. Br J Surg. 1991 Sep;78(9):1108-10.

9. Griffiths RW, Briggs JC. Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma. Ann R Coll Surg Engl. 1985 Mar;67(2):75-8.

10. Murchie P, Raja EA, Lee AJ, Campbell NC. Mortality and morbidity after initial diagnostic excision biopsy of cutaneous melanoma in primary versus secondary care. Br J Gen Pract. 2013 Aug;63(613):e563-72.

11. Melchi CF1, Mele A, Baliva G, Sciò M, Fucci M, Pasquini P, Corona R. Prognostic value of anesthesia type for patients treated for cutaneous melanoma. Dermatol Surg. 1995 Sep; 21(9):786-8.

12. Seebacher C1, Heubaum F, Küster P, Steinert W, Koch R. Comparative analysis of narcosis and local anesthesia in surgery of malignant melanoma of the skin Hautarzt. 1990 Mar; 41(3):137-41.

13. Schlagenhauff B1, Ellwanger U, Breuninger H, Stroebel W, Rassner G, Garbe C. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma Melanoma Res. 2000 Apr; 10(2):165-9.

14. Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol. 2002 Mar;3(3):159-65.

15. Buslach N, Foulad DP, Saedi N, Mesinkovska NA. Treatment Modalities for Cherry Angiomas: A Systematic Review. Dermatol Surg. 2020 Dec;46(12):1691-1697

16. Mulhem E, Pinelis S. Treatment of nongenital cutaneous warts. Am Fam Physician. 2011 Aug 1;84(3):288-93.

17. Клинические рекомендации американской академии дерматологии 

18. Wheatley K, Wilson JS, Gaunt P, Marsden JR: Surgical excision margins in primary cutaneous melanoma: A meta-analysis and Bayesian probability evaluation. Cancer Treat Rev 2016, 42:73-81.

19. Wheatley K, Wilson JS, Gaunt P, Marsden JR: Reply to response to Wheatley et al., "Surgical excision margins in primary cutaneous melanoma: A meta-analysis and Bayesian probability evaluation" Cancer Treatment Reviews April 2016;45:76. Cancer Treat Rev 2016. 

20. Veronesi U, Cascinelli N, Adamus J, Balch C, Bandiera D, Barchuk A, Bufalino R, Craig P, De Marsillac J, Durand JC et al: Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med 1988, 318(18):1159-1162. 

21. Ringborg U, Andersson R, Eldh J, Glaumann B, Hafstrom L, Jacobsson S, Jonsson PE, Johansson H, Krysander L, Lagerlof B: Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group. Cancer 1996, 77(9):1809-1814.

22. Cohn-Cedermark G, Rutqvist LE, Andersson R, Breivald M, Ingvar C, Johansson H, Jonsson PE, Krysander L, Lindholm C, Ringborg U: Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm. Cancer 2000, 89(7):1495-1501. 

23. Balch CM, Urist MM, Karakousis CP, Smith TJ, Temple WJ, Drzewiecki K, Jewell WR, Bartolucci AA, Mihm MC, Jr., Barnhill R et al: Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg 1993, 218(3):262-267; discussion 267-269. 

24. Balch CM, Soong SJ, Smith T, Ross MI, Urist MM, Karakousis CP, Temple WJ, Mihm MC, Barnhill RL, Jewell WR et al: Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol 2001, 8(2):101-108. 

25. Khayat D, Rixe O, Martin G, Soubrane C, Banzet M, Bazex JA, Lauret P, Verola O, Auclerc G, Harper P et al: Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer 2003, 97(8):1941-1946. 

26. Thomas JM, Newton-Bishop J, A"Hern R, Coombes G, Timmons M, Evans J, Cook M, Theaker J, Fallowfield M, O"Neill T et al: Excision margins in high-risk malignant melanoma. N Engl J Med 2004, 350(8):757-766.

27. Gillgren P, Drzewiecki KT, Niin M, Gullestad HP, Hellborg H, Mansson-Brahme E, Ingvar C, Ringborg U: 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial. Lancet 2011, 378(9803):1635-1642. 

28. Ogawa R. The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids: A 2020 Update of the Algorithms Published 10 Years Ago. Plast Reconstr Surg. 2022 Jan 1;149(1):79e-94e. doi: 10.1097/PRS.0000000000008667. PMID: 34813576; PMCID: PMC8687618.

29. Hocker TL, Alikhan A, Comfere NI, Peters MS. Favorable long-term outcomes in patients with histologically dysplastic nevi that approach a specimen border. J Am Acad Dermatol. 2013 Apr;68(4):545-51. doi: 10.1016/j.jaad.2012.09.031.

30. Kmetz EC, Sanders H, Fisher G, Lang PG, Maize JC Sr. The role of observation in the management of atypical nevi. South Med J 2009;102:45–48. 

31. Bryan Hiscox, MD, Melissa R. Hardin, MD, Ida F. Orengo, MD, Theodore Rosen, MD, Mohsin Mir, MD, A. Hafeez Diwan, MD. PhD Recurrence of moderately dysplastic nevi with positive histologic margins. Journal of the American Academy of Dermatology, Volume 76, Issue 3, Pages 527–530

32. Fleming NH, Egbert BM, Kim J, Swetter SM. Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi. JAMA Dermatol. 2016 Dec 1;152(12):1327-1334. doi: 10.1001/jamadermatol.2016.2869.  

33. Kim CC1, Swetter SM2, Curiel-Lewandrowski C3, Grichnik JM4, Grossman D5, Halpern AC6, Kirkwood JM7, Leachman SA8, Marghoob AA6, Ming ME9, Nelson KC10, Veledar E11, Venna SS12, Chen SC13. Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement.JAMA Dermatol. 2015 Feb;151(2):212-8. doi: 10.1001/jamadermatol.2014.2694.

34. Strazzula L1, Vedak P1, Hoang MP2, Sober A1, Tsao H1, Kroshinsky D3. The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis.J Am Acad Dermatol. 2014 Dec;71(6):1071-6. doi: 10.1016/j.jaad.2014.08.025. Epub 2014 Sep 26.

35. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, Melchi CF. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005 Jan;41(1):28-44.

36. Pampena R, Kyrgidis A, Lallas A, Moscarella E, Argenziano G, Longo C. A meta-analysis of nevus-associated melanoma: Prevalence and practical implications. J Am Acad Dermatol. 2017 Nov;77(5):938-945.e4. doi: 10.1016/j.jaad.2017.06.149. Epub 2017 Aug 29. Review.

37. Jasper P, Jungbauer WN, Poupore NS, Nguyen SA, Howell J, Neville BW, Day TA. Mucosal Melanoma In Situ of the Oral Cavity: A Case Report and Systematic Review of the Literature. Turk Arch Otorhinolaryngol. 2022 Sep;60(3):161-169.

38. DePalo DK, Elleson KM, Carr MJ, Spiess PE, Zager JS. Genitourinary melanoma: An overview for the clinician. Asian J Urol. 2022 Oct;9(4):407-422. doi: 10.1016/j.ajur.2022.01.003. Epub 2022 Jun 2. PMID: 36381597; PMCID: PMC9643129.

39. Huang Q, Zhang XH, Guo LJ, He YJ. Surgery on primary melanoma of the breast. Transl Cancer Res. 2019 Oct;8(Suppl 5):S463-S468.

40. Peño Muñoz L, Boix Clemente C, Martí Romero L, Navarro Peiró C, Pérez Zahonero MD, Alemany Pérez G, Martínez Escapa V, Moreno Torres B. A rare endoscopic finding: primary esophageal melanoma. Rev Esp Enferm Dig. 2022 Nov 10.

41. Navajas Hernández P, Del Pino Bellido P, Aparcero López R, Machuca Aguado J, Caunedo Álvarez Á. A rare gastrointestinal tumor: primary gastric melanoma. Rev Esp Enferm Dig. 2022 Oct 20;116.

42. Temperley HC, O'Sullivan NJ, Keyes A, Kavanagh DO, Larkin JO, Mehigan BJ, McCormick PH, Kelly ME. Optimal surgical management strategy for treatment of primary anorectal malignant melanoma - a systematic review and meta-analysis. Langenbecks Arch Surg. 2022 Dec;407(8):3193-3200.

43. Stålhammar G, Williams PA, Landelius T. The prognostic implication of latitude in uveal melanoma: a nationwide observational cohort study of all patients born in Sweden between 1947 and 1989. Discov Oncol. 2022 Oct 31;13(1):116

44. Pack, G. T., & Scharnagel, I. M. (1951). The prognosis for malignant melanoma in the pregnant woman. Cancer, 4(2), 324–334.

45. Byrd BF Jr, McGanity WJ. The effect of pregnancy on the clinical course of malignant melanoma. South Med J. 1954;47: 196-200.

46. Martínez-Campayo N, Paradela de la Morena S, Pértega-Díaz S, Iglesias Pena L, Vihinen P, Mattila K, Lens MB, Tejera-Vaquerizo A, Fonseca E. Survival of Women Previously Diagnosed of Melanoma with Subsequent Pregnancy: A Systematic Review and Meta-Analysis and a Single-Center Experience. J Clin Med. 2021 Dec 24;11(1):83.

47. Driscoll MS, Martires K, Bieber AK, Pomeranz MK, Grant-Kels JM, Stein JA. Pregnancy and melanoma. J Am Acad Dermatol. 2016 Oct;75(4):669-678.

48. Wise SR, Capra G, Martin P, Wallace D, Miller C. Malignant melanoma transformation within a nevus of Ito. J Am Acad Dermatol. 2010 May;62(5):869-74.

49. Scard C, Aubert H, Wargny M, Martin L, Barbarot S. Risk of melanoma in congenital melanocytic nevi of all sizes: A systematic review. J Eur Acad Dermatol Venereol. 2023 Jan;37(1):32-39.

50. Borgenvik TL, Karlsvik TM, Ray S, Fawzy M, James N. Blue nevus-like and blue nevus-associated melanoma: a comprehensive review of the literature. ANZ J Surg. 2017 May;87(5):345-349.

51. Murali R, McCarthy SW, Scolyer RA. Blue nevi and related lesions: a review highlighting atypical and newly described variants, distinguishing features and diagnostic pitfalls. Adv Anat Pathol. 2009 Nov;16(6):365-82.

52. Zembowicz A, Phadke PA. Blue nevi and variants: an update. Arch Pathol Lab Med. 2011 Mar;135(3):327-36.

53. Pflugfelder A1, Weide B, Eigentler TK, Forschner A, Leiter U, Held L, Meier F, Garbe C. Incisional biopsy and melanoma prognosis: Facts and controversies. Clin Dermatol. 2010 May-Jun;28(3):316-8. doi: 10.1016/j.clindermatol.2009.06.013.

54. Argenziano G, Fabbrocini G, Carli P, et al. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist. Arch Dermatol 1998;134(12):1563–70.

55. www.ncbi.nlm.nih.gov/medgen/137762 - определение пограничного (юнкционального невуса) от National Institutes of Health (NIH)

56. Goldgar DE, Cannon-Albright LA, Meyer LJ, Piepkorn MW, Zone JJ, Skolnick MH. Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst. 1991 Dec 4;83(23):1726-33.

57. Nevogenesis: Mechanisms and Clinical Implications of Nevus Development. Ashfaq A. Marghoob (Ed.), 2012

58. Каприн А.Д., Старинский В.В., Шахзадова А.О., ред. Злокачественные новообразования в России в 2020 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена — филиал ФГБУ «НМИЦ радиологии» Министерства здравоохранения Российской Федерации; 2021.

59. De Decker I, Hoeksema H, Verbelen J, Vanlerberghe E, De Coninck P, Speeckaert MM, Blondeel P, Monstrey S, Claes KEY. The use of fluid silicone gels in the prevention and treatment of hypertrophic scars: a systematic review and meta-analysis. Burns. 2022 May;48(3):491-509.

60. Malladi NSN, Chikhalkar SB, Khopkar U, Kharkar V. A descriptive observational study on clinical and dermoscopic features of benign melanocytic neoplasms. Indian J Dermatol Venereol Leprol. 2020 May-Jun;86(3):251-261.

61. Scope et al.: Nonmelanocytic lesions defying the two-step dermoscopy algorithm. Dermatol Surg 2006;32:1398-406.